Monitoring leflunomide (Arava) as a new potential teratogen
Version of Record online: 11 APR 2002
Copyright © 2002 Wiley-Liss, Inc.
Volume 65, Issue 5, pages 200–202, May 2002
How to Cite
Lyons Jones, K., Johnson, D. L. and Chambers, C. D. (2002), Monitoring leflunomide (Arava) as a new potential teratogen. Teratology, 65: 200–202. doi: 10.1002/tera.10058
- Issue online: 11 APR 2002
- Version of Record online: 11 APR 2002
- 2001. Teratogen update. Reproductive risks of leflunomide (Arava), a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide whom are contemplating fathering a child. Teratology 63: 106–112. .
- 2001. Post-marketing surveillance for human teratogenicity: a model approach. Teratology 64: 252–261. , , , , , , , , , .